Rolando and Melissa Toyos talk about their current research into intense pulse light (IPL) therapy for dry eye disease. IPL therapy is a light treatment applied to the skin to stimulate the meibomian glands to produce a better tear. The current study looks at the efficacy of IPL versus meibomian gland expression, and the results will be available in around 6 months. Another area of research is the platelet rich plasma (PRP) eye drops in the treatment of a number of conditions including oculoplastic procedures.
Keywords: ISOPT 2018, Meibomian glands, dry eye disease, IPL, intense pulse light therapy, clinical trial, oculoplastics. PRP, platelet rich plasma
For more information about ISOPT Clinical please visit: www.isoptclinical.com
Share this Video
Related Videos In Oculoplastic Surgery
Raymond Douglas, Hawaiian Eye and Retina 2023: Treatment options for thyroid eye disease
We were delighted to speak with Dr Raymond Douglas (Cedars-Sinai Medical Center, Los Angeles, CA, USA) about advances in treatment options for patients with thyroid eye disease. Questions: What have been the most important recent treatment advances in thyroid eye disease (TED)? (0:18) What factors should affect treatment decisions in TED? […]
Raymond Douglas, Hawaiian Eye and Retina 2023: Update on thyroid eye disease
It was a pleasure to catch up with Dr Raymond Douglas (Cedars-Sinai Medical Center, Los Angeles, CA, USA), who talked us through the latest updates in thyroid eye disease and the reasons it is so often misdiagnosed. Questions: Could you give us a brief overview of the relationship between hyperthyroidism and thyroid eye […]
Raymond Douglas, Hawaiian Eye 2021: Approach to Brow Ptosis
It was a pleasure to speak with Raymond Douglas (Cedars-Sinai Medical Center, Los Angeles, CA, USA) about his work on brow ptosis, and the pros and cons of the surgical techniques for brow ptosis. Questions What are the causes of brow ptosis? (00:20) What are the challenges of the surgical correction of brow ptosis? (01:08) […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!